On June 11th, Gelunhui reported that Shaanxi Kanghui Pharmaceutical (603139.SH) has received the first performance compensation of 2 million yuan from Hongfu Medicine on the date of this announcement. Lansheng has not yet fully fulfilled its performance commitment compensation obligation.
康惠制药(603139.SH)：收到200万元业绩补偿款
Shaanxi Kanghui Pharmaceutical (603139.SH): Received a performance compensation of 2 million yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.